Midostaurin |
PKC-412; PKC-412A; CGP-41231; CGP-41251 |
Approved |
Novartis Pharma Ag |
Rydapt |
EU |
Leukemia, Myeloid, Acute; Mastocytosis |
Novartis Europharm Ltd |
2017-04-28 |
Hematologic Neoplasms; Leukemia; Mastocytosis, Systemic; Myelodysplastic Syndromes; Leukemia, Mast-Cell; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Hepatic Insufficiency; Leukemia, Myeloid, Acute; Mastocytosis |
Details
|
Ponatinib Hydrochloride |
AP24534 hydrochloride; AP24534-HCL; AP24534 HCl; INCB-84344; AP-24534 |
Approved |
Ariad |
Iclusig |
Japan |
Precursor Cell Lymphoblastic Leukemia-Lymphoma; Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
Otsuka Holdings Co Ltd |
2012-12-14 |
Blast Crisis; Carcinoma, Non-Small-Cell Lung; Leukemia, Biphenotypic, Acute; Thyroid Neoplasms; Lymphoma; Leukemia, Myeloid, Acute; Leukemia, Myeloid, Chronic-Phase; Gastrointestinal Stromal Tumors; Philadelphia Chromosome; Medullary thyroid cancer (MTC); Common Bile Duct Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Glioblastoma; Leukemia, Myelomonocytic, Chronic; Neoplasms; Small Cell Lung Carcinoma; Adenocarcinoma of Lung; Head and Neck Neoplasms; Solid tumours; Leukemia, Myeloid, Accelerated Phase; Leukemia; Hematologic Neoplasms |
Details
|
Avapritinib |
BLU-285; CS-3007 |
Approved |
Blueprint Medicines Corp |
Ayvakit, Ayvakyt, 泰吉华 |
EU |
Mastocytosis, Systemic |
Blueprint Medicines (Netherlands) Bv |
2020-01-09 |
Solid tumours; Hematologic Neoplasms; Esophageal Neoplasms; Stomach Neoplasms; Mastocytosis, Systemic; Central Nervous System Neoplasms; Leukemia, Mast-Cell; Sarcoma; Breast Neoplasms; Gastrointestinal Stromal Tumors; Colorectal Neoplasms; Lung Neoplasms; Melanoma; Adenocarcinoma |
Details
|
Lenvatinib Mesylate |
ER-203492-00; E-7080; MK-7902 |
Approved |
Eisai Co Ltd |
Kisplyx, Lenvima, Lenvima/Kisplyx, 乐卫玛 |
Japan |
Carcinoma, Renal Cell |
Merck Sharp & Dohme Corp |
2015-02-13 |
Liver Diseases; Paraganglioma; Neoplasm Metastasis; Thyroid Cancer, Papillary; Melanoma; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Glioma; Lymphoma; Endometrial Neoplasms; Thyroid Neoplasms; Hepatic Insufficiency; Osteosarcoma; Cholangiocarcinoma; Breast Neoplasms; Solid tumours; Neuroendocrine Tumors; Carcinoma, Adenoid Cystic; Adenocarcinoma, Follicular; Kidney Diseases; Neoplasms; Adenocarcinoma of Lung; Thyroid Carcinoma, Anaplastic; Pheochromocytoma; Renal Insufficiency; Esophageal Neoplasms; Carcinoma, Renal Cell; Ovarian Neoplasms; Liver Neoplasms; Biliary Tract Neoplasms |
Details
|
Pexidartinib |
PLX-3397 |
Approved |
Daiichi Sankyo Co Ltd |
Turalio |
United States |
Giant Cell Tumor of Tendon Sheath |
Daiichi Sankyo Inc |
2019-08-02 |
Prostatic Neoplasms; Neoplasm Metastasis; Carcinoma, Non-Small-Cell Lung; Melanoma; Leukemia, Myeloid, Acute; Colorectal Neoplasms; Gastrointestinal Stromal Tumors; Giant Cell Tumors; Neurofibroma, Plexiform; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Neurofibrosarcoma; Sarcoma; Ovarian Neoplasms; Breast Neoplasms; Arthritis, Rheumatoid; Pancreatic Neoplasms; Glioblastoma; Neoplasms; Hodgkin Disease; Synovitis, Pigmented Villonodular; Squamous Cell Carcinoma of Head and Neck; Leukemia, Promyelocytic, Acute; Giant Cell Tumor of Tendon Sheath; Solid tumours |
Details
|
Regorafenib |
DAST; BAY-73-4506 |
Approved |
Bayer AG |
Stivarga, Resihance |
Mainland China |
Gastrointestinal Stromal Tumors |
Bayer Pharma Ag |
2012-09-27 |
Leukemia, Myeloid, Acute; Sarcoma; Gastrinoma; Osteosarcoma; Sarcoma, Ewing; Colorectal Neoplasms; Peritoneal Neoplasms; Gastrointestinal Stromal Tumors; Bile Duct Neoplasms; Fallopian Tube Neoplasms; Esophageal adenocarcinoma; Adenoma; Thyroid Neoplasms; Lung Neoplasms; Thymoma; Carcinoma, Hepatocellular; Adenocarcinoma; Melanoma; Neoplasm Metastasis; Gastrointestinal Neoplasms; Somatostatinoma; Carcinoma, Islet Cell; Ovarian Neoplasms; Liver Neoplasms; Hemangiosarcoma; Esophageal Neoplasms; Stomach Neoplasms; Carcinoma, Renal Cell; Rectal Neoplasms; Carcinoid Tumor; Insulinoma; Solid tumours; Colonic Neoplasms; Neoplasms; Carcinoma, Ovarian Epithelial; Pancreatic Neoplasms; Small Cell Lung Carcinoma; Glioblastoma; Carcinoma, Transitional Cell; Carcinoma, Adenoid Cystic; Glucagonoma |
Details
|
Anlotinib Dihydrochloride |
AL-3818 |
Approved |
Advenchen Laboratories Llc, Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd |
福可维 |
Mainland China |
Thyroid Neoplasms |
Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd |
2018-05-08 |
Esophageal Squamous Cell Carcinoma; Bone Neoplasms; Peritoneal Neoplasms; Colorectal Neoplasms; Hepatic Insufficiency; Gastrointestinal Stromal Tumors; Urologic Neoplasms; Sarcoma, Alveolar Soft Part; Endometrial Neoplasms; Gallbladder Neoplasms; Bile Duct Diseases; Thyroid Neoplasms; Fallopian Tube Neoplasms; Lung Neoplasms; Glioma; Carcinoma, Non-Small-Cell Lung; Uterine Cervical Neoplasms; Melanoma; Carcinoma, Hepatocellular; Osteoma; Small Cell Lung Carcinoma; Head and Neck Neoplasms; Solid tumours; Biliary Tract Neoplasms; Drug-Related Side Effects and Adverse Reactions; Ovarian Neoplasms; Esophageal Neoplasms; Thoracic Neoplasms; Carcinoma, Renal Cell; Stomach Neoplasms; Leiomyosarcoma; Lymphoma, Large B-Cell, Diffuse; Neoplasms; Carcinoma, Ovarian Epithelial; Sarcoma, Synovial; Neuroendocrine Tumors; Liver Diseases; Sarcoma; Medullary thyroid cancer (MTC); Nasopharyngeal Carcinoma |
Details
|
Sorafenib Tosylate |
NSC-724772; BAY-43-0006; BAY-43-9006; BAY-54-9085 |
Approved |
Onyx Pharmaceuticals Inc |
Nexavar, 多吉美 |
EU |
Thyroid Neoplasms |
Bayer AG |
2005-12-01 |
Liver Neoplasms; Leukemia, Myeloid; Lymphoma, B-Cell, Marginal Zone; Rhabdomyosarcoma; Head and Neck Neoplasms; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Fibromatosis, Aggressive; Leiomyosarcoma; Kidney Neoplasms; Leukemia, Erythroblastic, Acute; Solid tumours; Lymphoma, T-Cell, Peripheral; Ovarian Neoplasms; Recurrence; Carcinoma, Renal Cell; Esophageal Neoplasms; Vipoma; Rectal Neoplasms; Squamous Cell Carcinoma of Head and Neck; Histiocytoma, Malignant Fibrous; Carcinoma, Islet Cell; Hemangiosarcoma; Carcinoid Tumor; Carcinoma; Insulinoma; Stomach Neoplasms; Neoplasms; Pancreatic Neoplasms; Multiple Endocrine Neoplasia Type 2a; Hypertension, Portal; Carcinoma, Transitional Cell; Carcinoma, Verrucous; Thyroid Carcinoma, Anaplastic; Myelodysplastic Syndromes; Glioblastoma; Carcinoma, Ovarian Epithelial; Leukemia, Myelomonocytic, Acute; Colonic Neoplasms; Lymphoma, Large B-Cell, Diffuse; Lymphomatoid Granulomatosis; Wilms Tumor; Leukemia, Myelomonocytic, Chronic; Lymphoma, Large-Cell, Immunoblastic; S |
Details
|
Dasatinib Hydrate |
BMS-354825; NSC-732517 |
Approved |
Bristol-Myers Squibb Company |
施达赛, Spricel, Sprycel, Spraysel |
Mainland China |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Precursor Cell Lymphoblastic Leukemia-Lymphoma |
Bristol-Myers Squibb Pharma Eeig |
2006-06-28 |
Astrocytoma; Intraocular Lymphoma; Lymphoma, Large-Cell, Anaplastic; Lymphoma, T-Cell; Lymphoma, T-Cell, Cutaneous; Lymphoma, Non-Hodgkin; Fallopian Tube Neoplasms; Lung Neoplasms; Gastrointestinal Stromal Tumors; Giant Cell Tumor of Bone; Primary Myelofibrosis; Gliosarcoma; Burkitt Lymphoma; Peritoneal Neoplasms; Leukemia, Myeloid, Chronic-Phase; Sarcoma, Ewing; Neurofibrosarcoma; Sarcoma; Cholangiocarcinoma; Brain Neoplasms; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Lymphoma, Mantle-Cell; Lymphoma, Follicular; Prostatic Neoplasms; Neoplasm Metastasis; Mastocytosis; Tongue Neoplasms; Carcinoma, Hepatocellular; Adenocarcinoma; Carcinoma, Non-Small-Cell Lung; Leukemia, Large Granular Lymphocytic; Leukemia, T-Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Mycosis Fungoides; Melanoma; Heart Arrest; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Endometrial Neoplasms; Leukemia, Myeloid, Acute; Hemangiopericytoma; Sarcoma, Alveolar Soft Part; Uterine Neoplasms; Laryngeal Neoplasms; Waldenstrom Macroglobuli |
Details
|
Cabozantinib S-malate |
XL-184; BMS-907351 |
Approved |
Exelixis Inc |
Cometriq, Cabometyx |
Japan |
Carcinoma, Renal Cell |
Takeda |
2012-11-29 |
Osteosarcoma; Thyroid Neoplasms; Gliosarcoma; Colorectal Neoplasms; Peritoneal Neoplasms; Bile Duct Neoplasms; Hepatic Insufficiency; Astrocytoma; Breast Neoplasms; Sarcoma, Ewing; Lymphoma; Carcinoma, Adenosquamous; Adenocarcinoma, Clear Cell; Sarcoma, Clear Cell; Medullary thyroid cancer (MTC); Cholangiocarcinoma; Prostatic Neoplasms; Neurofibroma, Plexiform; Urethral Neoplasms; Carcinoma, Neuroendocrine; Meningioma; Carcinoma, Non-Small-Cell Lung; Paraganglioma; Melanoma; Carcinoma, Endometrioid; Thyroid Cancer, Papillary; Adenocarcinoma; Neoplasms, Germ Cell and Embryonal; Carcinoma, Hepatocellular; Neuroblastoma; Glioma; Leukemia, Myeloid, Acute; Carcinoma, Squamous Cell; Endometrial Neoplasms; Lung Neoplasms; Sarcoma, Alveolar Soft Part; Uterine Neoplasms; Fallopian Tube Neoplasms; Carcinoid Tumor; Neurofibromatoses; Seminoma; Carcinoma, Transitional Cell; Glioblastoma; Rejection of liver transplantation; Carcinoma, Merkel Cell; Hepatoblastoma; Pain; Pheochromocytoma; Neoplasms; Carcinoma, Renal Cell; B |
Details
|
Pazopanib Hydrochloride |
GSK-786034; GW-786034B; SB-786034; GW-786034 |
Approved |
Glaxosmithkline Plc, Novartis Pharma Ag |
维全特, Armala, Votrient, Patorma |
Mainland China |
Carcinoma, Renal Cell |
Novartis Pharma Schweiz Ag |
2009-10-19 |
Peritoneal Neoplasms; Lymphoma; Uterine Neoplasms; Lung Neoplasms; Carcinoma, Small Cell; Thyroid Neoplasms; Gastrointestinal Stromal Tumors; Gliosarcoma; Carcinoma, Mucoepidermoid; Genital Neoplasms, Female; Uterine Cervical Diseases; Choriocarcinoma; Colorectal Neoplasms; Neuroblastoma; Osteosarcoma; Gastrinoma; Psoriasis; Brain Neoplasms; Urethral Neoplasms; Breast Neoplasms; Medullary thyroid cancer (MTC); von Hippel-Lindau Disease; Gastrointestinal Neoplasms; Carcinoma, Hepatocellular; Melanoma; Endodermal Sinus Tumor; Neoplasms, Germ Cell and Embryonal; Paraganglioma; Thyroid Cancer, Papillary; Neoplasm Metastasis; Uterine Cervical Neoplasms; Breast Neoplasms, Male; Prostatic Neoplasms; Macular Degeneration; Carcinoma, Non-Small-Cell Lung; Fallopian Tube Neoplasms; Leukemia, Myeloid, Acute; Glioma; Germinoma; Carcinoma, Neuroendocrine; Carcinoma, Embryonal; Carcinoma, Squamous Cell; Telangiectasia, Hereditary Hemorrhagic; Thyroid Carcinoma, Anaplastic; Neoplasms; Carcinoid Tumor; Herpes Genitalis; Pheoc |
Details
|
Sunitinib Malate |
PHA-290940; SU-010398; SU-11248; PNU-290940AD; PHA-290940AD; GB-102; PNU-290940; SU-011248-L-malate salt |
Approved |
Pfizer Pharmaceuticals Ltd (China) |
索坦, Sutent |
Japan |
Pancreatic neuroendocrine tumors (pNET) |
Pfizer Inc |
2006-01-26 |
Teratoma; Ovarian Neoplasms; Fibromatosis, Aggressive; Solid tumours; Intestinal Neoplasms; Kidney Neoplasms; Liver Neoplasms; Leiomyosarcoma; Fibrosarcoma; HIV Infections; Head and Neck Neoplasms; Lymphoma, B-Cell, Marginal Zone; Lymphoma, B-Cell; Leukemia, Myeloid, Accelerated Phase; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphoma, T-Cell, Peripheral; Ependymoma; Carcinoma, Renal Cell; Histiocytoma, Malignant Fibrous; Carcinoma; Hemangioblastoma; Carcinoma, Islet Cell; Stomach Neoplasms; Squamous Cell Carcinoma of Head and Neck; Thoracic Neoplasms; Leukemia, Hairy Cell; Abdominal Neoplasms; Esophageal Neoplasms; Polycythemia Vera; Pelvic Neoplasms; Pheochromocytoma; Glioblastoma; Neurofibromatoses; Pancreatic Neoplasms; Pancreatic neuroendocrine tumors (pNET); Salivary Gland Neoplasms; Small Cell Lung Carcinoma; Leukemia, Myelomonocytic, Chronic; Myelodysplastic Syndromes; Hodgkin Disease; Lymphoma, Large B-Cell, Diffuse; Carcinoma, Ovarian Epithelial; Carcinoma, Papillary; Neoplasms; I |
Details
|
Olverembatinib |
D-824; GZD-824; APG-1351; GIBH-824; HQP-1351 |
Approved |
Guangzhou Institute Of Biomedicine And Health, Chinese Academy Of Sciences |
耐立克 |
Mainland China |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Accelerated Phase |
Guangzhou Shunjian Biomedical Technology Co Ltd |
2021-11-25 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Accelerated Phase; Leukemia; Leukemia, Myeloid; Solid tumours; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Gastrointestinal Stromal Tumors |
Details
|
Ripretinib |
DCC-2618 |
Approved |
Deciphera |
擎乐, Qinlock |
United Kingdom |
Gastrointestinal Stromal Tumors |
Deciphera Pharmaceuticals Llc |
2020-05-15 |
Mastocytosis, Systemic; Neoplasms; Gastrointestinal Stromal Tumors |
Details
|
Imatinib mesylate |
CGP-57148B; CGP-57148; STI-571; QTI-571; CTI-571; VR325; AER-901; YD-312; TNX-201 |
Approved |
Novartis Pharma Ag |
glivic, 格列卫, Gleevec, Ruvise, Glivec, Gleevec/Glivec |
United States |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
Novartis Pharma Ag |
2001-05-10 |
Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Hypereosinophilic Syndrome; Leukemia, Myeloid, Accelerated Phase; Ovarian germ cell tumor; Ovarian Neoplasms; Fibrosarcoma; Solid tumours; Loiasis; Lymphoma, B-Cell, Marginal Zone; Genital Diseases, Male; Head and Neck Neoplasms; Neoplasm, Residual; Hematopoietic stem cell transplantation (HSCT); Diabetes Mellitus, Type 1; Hypertension, Pulmonary; Leukemia, Hairy Cell; Histiocytoma, Malignant Fibrous; Rectal Neoplasms; Stomach Neoplasms; Abdominal Neoplasms; Desmoplastic Small Round Cell Tumor; Polycythemia Vera; Genital Neoplasms, Male; Rhinitis, Allergic, Seasonal; Myeloproliferative Disorders; Scleroderma, Systemic; Myelodysplastic Syndromes; Leukemia, Myelomonocytic, Chronic; Leukemia-Lymphoma, Adult T-Cell; Neoplasms; Colonic Neoplasms; Small Cell Lung Carcinoma; Dermatofibrosarcoma; Seminoma; Graft vs Host Disease; Lymphoma, Large B-Cell, Diffuse; Carcinoma, Ovarian Epithelial; Plasmacytoma; Immunoglobulin Light-chain Amyloidosis; Hodgkin Disea |
Details
|